Results 231 to 240 of about 8,379,611 (261)

Highly active antiretroviral therapy and cervical intraepithelial neoplasia

AIDS, 2002
Highly active antiretroviral therapy (HAART) has improved HIV prognosis, but its effect on cervical intraepithelial neoplasia (CIN), which is associated with HIV, is uncertain. Among 71 HAART-treated women the prevalence of CIN before HAART was 55%. After a median of 10 months after starting HAART the prevalence had increased to 62% (P = 0.20); 13% of ...
Antonia L, Moore, Caroline A, Sabin, Sara, Madge, Amanda, Mocroft, Wendy, Reid, Margaret A, Johnson   +5 more
openaire   +2 more sources

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

AIDS, 2006
To determine the effectiveness of HAART by race/ethnicity.Prospective multicenter cohort study.We studied 991 African-Americans and 911 European-Americans enrolled in the United States Military's Tri-Service AIDS Clinical Consortium Natural History Study who had dates of HIV seroconversion known within 5 years and followed between 1990 and 2002.
Michael J, Silverberg, Scott A, Wegner, Mark J, Milazzo, Rosemary G, McKaig, Carolyn F, Williams, Brian K, Agan, Adam W, Armstrong, Stephen J, Gange, Clifton, Hawkes, Robert J, O'Connell, Sunil K, Ahuja, Matthew J, Dolan   +11 more
openaire   +2 more sources

Symptom Management in the Age of Highly Active Antiretroviral Therapy

Journal of the Association of Nurses in AIDS care, 2004
In the not too distant past, I was one of two nurses invited to participate on a working panel to develop treatment guidelines for HIV-related nausea. Prior to the meeting, each panel member was assigned a topic to review and present. Myphysician co-panelists were more than surprised when theywent to review the literature because little information on ...
openaire   +2 more sources

Highly Active Antiretroviral Therapy in Neonates and Young Infants

Neonatal Network, 2004
SINCE THE U.S. PUBLIC HEALTH Service published its guidelines for the reduction of vertical transmission of human immunodeficiency virus (HIV) in 1994, Pediatric AIDS Clinical Trials Group (PACTG) 076 zidovudine (ZDV) regimen (Table 1) has been the standard of care in developed countries.1 The initial study of ZVD administration in mother-infant pairs ...
openaire   +2 more sources

Dealing With the Obstacles in Adhering to Highly Active Antiretroviral Therapy

Journal of the Association of Nurses in AIDS Care, 2006
Improving patient adherence to highly active antiretroviral therapy (HAART) is essential to effective treatment and represents a major challenge confronting healthcare providers. Because of their holistic perspective, nurses are uniquely qualified to identify the psychosocial and practical obstacles to full adherence and help patients deal with these ...
openaire   +2 more sources

[Highly Active AntiRetroviral Therapy and cryptosporidiosis].

Parassitologia, 2004
In HIV infected persons, Cryptosporidium parvum causes chronic diarrhoea, which can be life-threatening in persons with AIDS and with a low CD4+ T cell count. However, a specific and effective therapy for this opportunistic infection does not yet exist.
openaire   +1 more source

Adherence and Effectiveness of Highly Active Antiretroviral Therapy

Archives of Internal Medicine, 1998
H, Knobel, A, Carmona, S, Grau, J, Pedro-Botet, A, Díez   +4 more
openaire   +2 more sources

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

PLoS Medicine, 2005
Eduard Beck, Linda-Gail Bekker, Robin Wood   +2 more
exaly  

The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study

PLoS Medicine, 2011
Annelies van Rie, Sonia Napravnik, Marcel Yotebieng   +2 more
exaly  

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

Lancet, The, 2002
Robin Wood, Douglas Wilson, Motasim Badri   +2 more
exaly